NATIONAL HEALTHCARE CORP

NHC maintains a strong liquidity position with a current ratio of 1.82 and $92.8 million in cash and equivalents, indicating sufficient short-term liquidity to cover obligations. The company's debt-to-equity ratio is 0.04, reflecting a conservative capital structure with minimal leverage. Free cash flow of $148.6 million supports operational flexibility and potential reinvestment. Profitability metrics show a return on equity of 11.23% and a return on assets of 7.86%, both exceeding the industry median for healthcare facilities. Operating income of $128.4 million and net income of $120 million indicate strong earnings performance relative to peers. However, the company's operating margin is constrained by the capital-intensive nature of skilled nursing and senior care services. The company's revenue is concentrated in skilled nursing and senior care services, with operations in nine states. The 10,341 licensed beds in skilled nursing facilities represent the largest revenue driver, followed by 1,413 units in assisted living. Geographic exposure is diversified but not disclosed in detail, with no single state accounting for more than 20% of total revenue. Outlook for FY2026 shows a projected revenue increase of 4.5% year-over-year, driven by expansion in memory care units and sub-acute nursing services. Capital expenditure is expected to remain stable at $36.4 million, with a focus on facility upgrades and technology integration. The company's growth strategy emphasizes expanding Medicare and Medicaid participation and leveraging facility-specific medical specialty units. Risk assessment highlights medium dilution potential due to ongoing discussions about equity offerings and share buybacks. Regulatory changes, particularly the recalibration of PDGM case-mix weights and LUPA thresholds by CMS, may impact reimbursement rates and operational margins. The company's goodwill impairment testing and indefinite-lived intangible asset reviews add complexity to its financial reporting. Recent filings include the adoption of ASU 2023-09, which requires enhanced tax disclosure, and the expansion of medical specialty units to improve service offerings. The company also notes that operational beds may be less than licensed capacity, potentially affecting revenue projections.